Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

New microbially produced inhibitor of HSP expression in development at Mercian

April 1, 1999

O6-Benzylguanine shows potential for oral efficacy in humans

March 31, 1999

Studies on BTK inhibitors expected to result in discovery of new anticancer drugs

March 31, 1999

Results of Onconase trial in malignant mesothelioma reported

March 31, 1999

ACS highlights: Dainippon selects potent antitumor compound for development

March 30, 1999

New antileukemia agents synthesized at Hughes Institute

March 30, 1999

New differentiation-inducing vitamin D compounds from Japanese lab

March 30, 1999

U. of California reports new purine cyclin-dependent kinase inhibitors

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.